<p>Median CD4 (IQR) for patients initiated on ART, by adherence < or ≥95% based on drug-refill visits.</p
<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cell...
<p>Trends of median CD4<sup>+</sup> count at different periods of time of study participants on firs...
<p>All initiation rules are mutually exclusive. For example, if a child started ART with a CD4 count...
<p>Median CD4 (IQR) for patients initiated on ART, with CD4 ≤ or >100 ce...
<p>A) Median absolute CD4 cell count. B) Median CD4 gain 12 months after ART start.</p
a<p>These characteristics were matched between the two samples.</p>b<p>Note that 15.4% of participan...
<p>Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...
<p>Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by year of treatment initiation....
<p>Mean CD4<sup>+</sup> T-cell percentage (95% confidence interval) after ART initiation by regimen....
<p>Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by facility in the most recent y...
<p><sup>a</sup> Defined as those enrolling at CD4 ≤ 200 (in the expansion to CD4 ≤ 350 analysis) and...
<p><sup>1</sup>Data are % (proportion) of patients or median value (interquartile range).</p><p>Fact...
Introduction: Inspite of HAART, it has been found that viral replication persists even when viral lo...
<p>Percent of established patients meeting CD4 monitoring guidelines, 2009–2012.</p
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0122583#pone.0122583.g001" ...
<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cell...
<p>Trends of median CD4<sup>+</sup> count at different periods of time of study participants on firs...
<p>All initiation rules are mutually exclusive. For example, if a child started ART with a CD4 count...
<p>Median CD4 (IQR) for patients initiated on ART, with CD4 ≤ or >100 ce...
<p>A) Median absolute CD4 cell count. B) Median CD4 gain 12 months after ART start.</p
a<p>These characteristics were matched between the two samples.</p>b<p>Note that 15.4% of participan...
<p>Trends in median CD4 count and proportion of patients with CD4 count > 400 cells/μL over 10 years...
<p>Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by year of treatment initiation....
<p>Mean CD4<sup>+</sup> T-cell percentage (95% confidence interval) after ART initiation by regimen....
<p>Percentage of patients on d4T-, TDF-, and AZT-based ART regimens by facility in the most recent y...
<p><sup>a</sup> Defined as those enrolling at CD4 ≤ 200 (in the expansion to CD4 ≤ 350 analysis) and...
<p><sup>1</sup>Data are % (proportion) of patients or median value (interquartile range).</p><p>Fact...
Introduction: Inspite of HAART, it has been found that viral replication persists even when viral lo...
<p>Percent of established patients meeting CD4 monitoring guidelines, 2009–2012.</p
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0122583#pone.0122583.g001" ...
<p>Predictors of Remaining in Pre-ART Care or Initiating ART among Patients with CD4 Count >350 cell...
<p>Trends of median CD4<sup>+</sup> count at different periods of time of study participants on firs...
<p>All initiation rules are mutually exclusive. For example, if a child started ART with a CD4 count...
DOI
Add to ORKG